Author Index: G

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Gabler, N.
• EXPANDED CHOICE SETS INCREASE PATIENTS' WILLINGNESS TO COMPLETE ADVANCE DIRECTIVES
Gachoud, D.
• TRAINING PRIMARY CARE PHYSICIANS IN SHARED DECISION MAKING FOR COLORECTAL CANCER SCREENING. INSIGHTS FROM A STATEWIDE COLORECTAL CANCER SCREENING PROGRAM IN SWITZERLAND
Gaebler, J.
• PREFERENCES FOR COLORECTAL SCREENING TESTS AMONG A PREVIOUSLY UNSCREENED POPULATION

• IMPACT OF MULTIPLE TEST OPTIONS ON INTENT-TO-SCREEN AMONG A PREVIOUSLY UNSCREENED POPULATION
Gafni, A.
• THE DEVELOPMENT AND TESTING OF A DISCRETE CHOICE EXPERIMENT QUESTIONNAIRE TO MEASURE INDIVIDUALS' PREFERENCES FOR HEALTH OUTCOMES AND MEDICAL EXPENDITURES
Gaglani, M.
• CLASSIFICATION AND REGRESSION TREES (CART) ANALYSIS FOR PREDICTING INFLUENZA
Gajic-Veljanoski, O.
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Gallais, J. L.
• VALIDATION OF THE CONCEPTUAL FRAMEWORK OF THE DIVA QUESTIONNAIRE

• VALIDATION OF A DOMAIN ASSESSING THE ENGAGEMENT OF GENERAL PRACTITIONERS TOWARD VACCINATION USING THE RASCH MODEL
Garbayo, L. S.
• SYMPOSIUM: DO THE RIGHT THING - ETHICS, DECISION SCIENCE AND IMPLEMENTATION: AN INTERDISCIPLINARY SYMPOSIUM
Gaskin, D.
• EXAMINING DISPARITIES IN THE TREATMENT AND COSTS OF KNEE OSTEOARTHRITIS USING AN INTERACTIVE MARKOV MODEL
Gastl, G.
• CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?
Gaziano, T.
• ALL TAKING SOME OR SOME TAKING NONE? ASSESSING WHETHER DIFFERENT APPROACHES FOR MODELING DRUG COMPLIANCE AFFECT THE OPTIMAL DECISION FOR STATIN TREATMENT INITIATION
Geboers, A.
• CAREGIVERS' AND PATIENTS' RESPONSES TO THE IMPLEMENTATION OF A DECISION AID FOR PROSTATE CANCER TREATMENT
Gehlert, S.
• “IT SOUNDS LIKE SOME BS”: ACCEPTANCE AND REJECTION OF GENETIC RISK COMMUNICATION
Gellad, W.
• ESTIMATING THE PREVALENCE OF HEPATITIS C IN PENNSYLVANIA MEDICAID USING A MICROSIMULATION MODEL
Gemmell, J.
• USING MACHING LEARNING TO POPULATE A MARKOV MODEL BY MINING BIG DATA DIRECTLY FROM A HOSPITAL EHR
Georgieva, M.
• A MODEL-BASED COMPARISON OF EVALUATION STRATEGIES FOR URINARY TRACT MALIGNANT TUMORS IN PATIENTS WITH ASYMPTOMATIC MICROSCOPIC HEMATURIA
Gibson, B.
• PATIENT RESPONSE TO A DECISION SUPPORT TOOL IN DEVELOPMENT: VETERANS LIKE ME
Gibson, B.
• THE QUALITY OF RESEARCH ABSTRACTS IN EMERGENCY MEDICINE
Gibson, P.
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Gigučre, A.
• DO PRIMARY CARE CLINICIANS ASK PATIENTS WHAT MATTERS TO THEM? AN OBSERVATIONAL STUDY IN 5 FAMILY MEDICINE CLINICS

• ENGAGING PATIENTS AND OTHER STAKEHOLDERS IN THE DEVELOPMENT OF PATIENT DECISION AIDS: COMPARISONS OF CURRENT PRACTICES WITH USER-CENTERED DESIGN

• ENGAGEMENT OF MEMBERS OF MARGINALIZED POPULATIONS IN THE DEVELOPMENT OF PATIENT DECISION AIDS AND OTHER PATIENT-CENTERED TOOLS
Gildea, T.
• COST EFFECTIVENESS OF BRONCHIAL THERMOPLASTY IN PATIENTS WITH SEVERE UNCONTROLLED ASTHMA
Gilkey, M.
• WHAT LEADS PARENTS TO SAY YES, NO OR MAYBE TO HUMAN PAPILLOMAVIRUS VACCINATION? THE ROLE OF PROVIDER RECOMMENDATION QUALITY
Giraldo, M.
• COST-EFFECTIVENESS OF PROPHYLACTIC PERIOPERATIVE BETA-BLOCKERS USE IN PATIENTS UNDERGOING CARDIAC OR HIGH-RISK NON-CARDIAC SURGERY
Girdish, C.
• MEDICAL COST SAVINGS FROM MEDICATION ADHERENCE AND IMPLICATIONS FOR TARGETING BEHAVIORAL INTERVENTIONS
Gizlice, Z.
• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
Glouberman, S.
• ENGAGING PATIENTS AND OTHER STAKEHOLDERS IN THE DEVELOPMENT OF PATIENT DECISION AIDS: COMPARISONS OF CURRENT PRACTICES WITH USER-CENTERED DESIGN

• ENGAGEMENT OF MEMBERS OF MARGINALIZED POPULATIONS IN THE DEVELOPMENT OF PATIENT DECISION AIDS AND OTHER PATIENT-CENTERED TOOLS
Goeree, R.
• A COMPARISON OF DIFFERENT APPROACHES IN MODELLING FOR THE CONDUCT OF COST-EFFECTIVENESS ANALYSES: A CASE IN CHILDHOOD FLU VACCINATION
Gold, H. T.
• MENISCAL ALLOGRAFT TRANSPLANTATION IS A COST-EFFECTIVE ALTERNATIVE TO PARTIAL MENISCECTOMY FOR TORN LATERAL DISCOID MENISCUS
Gold, L.
• USE OF THE CHILD HEALTH UTILITY 9D INDEX IN AUSTRALIAN ADOLESCENTS WITH DENTAL CARIES
Goldhaber-Fiebert, J. D.
• DISTINGUISHING HIGH-RISK VERSUS LOW-RISK SUBGROUPS IN COMPARTMENTAL EPIDEMIC MODELS: WHERE TO DRAW THE LINE?

• OPTIMAL TIMING OF DRUG SENSITIVITY TESTING FOR PATIENTS ON FIRST-LINE TB TREATMENT IN INDIA

• COST-EFFECTIVENESS OF HIV PREEXPOSURE PROPHYLAXIS FOR INJECTION DRUG USERS IN THE UNITED STATES

• A NON-ITERATIVE METHOD OF IDENTIFYING THE COST-EFFECTIVENESS FRONTIER USING NET MONETARY BENEFITS AND ITS GRAPHICAL INTERPRETATION

• BETTER EPIDEMIC CONTROL FOR FUTURE AFRICAN EBOLA OUTBREAKS: DYNAMIC SIMULATION MODELING CALIBRATION AND ANALYSIS
Goldman, J.
• IMPORTANT FACTORS IN CLINICAL DECISION MAKING FOR RAPID STREPTOCOCCAL ANTIGEN TESTING: A SURVEY OF PEDIATRIC EMERGENCY DEPARTMENT (ED) PROVIDERS
Goldsack, J. C.
• THE VALUE OF DATA TRANSPARENCY AT THE POINT OF CARE
Goldsmith, L. J.
• WHY ARE SO MANY PATIENTS DISSATISFIED WITH KNEE REPLACEMENT SURGERY? REFLECTIONS AND RESULTS FROM A MULTIPHASE MIXED METHODS STUDY IN BRITISH COLUMBIA
Goldstein, D.
• ASSESSING THE ROLE OF SEQUENCING UP TO THREE LINES OF CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER TREATMENT: A COST EFFECTIVENESS ANALYSIS
Goldstein, M. K.
• PANEL: WHAT IS A "GOOD" MEDICAL DECISION? PERSPECTIVES FROM MULTIPLE STAKEHOLDERS: A SBM-SMDM CROSSTALK PANEL DISCUSSION
Golin, C. E.
• PATIENT PERCEPTIONS ABOUT COLORECTAL CANCER SCREENING AFTER VIEWING A DECISION AID TARGETED TO OLDER ADULTS

• RANDOMIZED TRIAL OF A DECISION AID TO PROMOTE APPROPRIATE COLORECTAL CANCER SCREENING AMONG OLDER ADULTS

• INFLUENCES ON PRIMARY CARE PROVIDERS' RECOMMENDATIONS FOR HYPOTHETICAL PROSTATE AND COLON CANCER SCREENING IN OLDER ADULTS: A WITHIN-SUBJECTS EXPERIMENT
Gollins, J.
• WHAT'S IMPORTANT TO PATIENTS? USING TOOLS FROM MARKETING AND EDUCATION TO ASSESS DISPARATE PERSPECTIVES AND IMPROVE DECISION SUPPORT TOOLS
Gońi, J. M. R.
• LESS IS MORE – EQ-5D-5L VALUE SETS BASED ON AN 8-PARAMETER NON-LINEAR MODEL PREDICTS LEFT-OUT STATES BETTER THAN A 20-PARAMETER MAIN EFFECTS MODEL
Gonzalez, J. M.
• GOOD NEWS AND BAD NEWS: THE PERCEIVED VALUE OF WHOLE GENOME SEQUENCING INFORMATION
Goodloe, R. J.
• GENERALIZED PROPENSITY SCORE MATCHING WITH MULTIPLE COHORTS: A CASE STUDY OF COMPARATIVE EFFECTIVENESS OF COMMON SECOND-LINE REGIMENS FOR NON-SMALL CELL LUNG CANCER IN THE US
Goodman, J.
• PANEL DISCUSSION: DECISION MAKING AMONG VULNERABLE POPULATIONS NEW TO THE HEALTH CARE SYSTEM
Gopal, V.
• OPTIMIZING REFERRAL TO RENAL CARE MANAGEMENT PROGRAM THROUGH USE OF A PREDICTIVE MODEL FOR TRANSITION TO DIALYSIS IN A MEDICARE ADVANTAGE POPULATION
Goss, C.
• A NOVEL TOOL TO EVALUATE THE ACCURACY OF PREDICTING SURVIVAL IN CYSTIC FIBROSIS
Govindarajan, A.
• BURDEN OF COMMUNITY-ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION IN ONTARIO, CANADA: A POPULATION-BASED STUDY
Grad, R.
• DO PRIMARY CARE CLINICIANS ASK PATIENTS WHAT MATTERS TO THEM? AN OBSERVATIONAL STUDY IN 5 FAMILY MEDICINE CLINICS
Graves, J.
• A DISCRETE EVENT MODEL FOR ASSESSING THE COST-EFFECTIVENESS OF PRECISION MEDICINE INITIATIVES
Green, T.
• RACIAL CONCORDANCE AND PERCEPTION OF HEALTHCARE PROVIDER'S COMMUNICATION SKILLS: DOES SOCIOECONOMIC STATUS MATTER?
Gregorich, S.
• VALUES-CONSISTENT DECISIONS WITH USE OF A PRENATAL TESTING DECISION SUPPORT GUIDE
Grenier, H.
• A MEASURE OF QUEBEC EMERGENCY PHYSICIANS' INTENTIONS TO USE WIKI-BASED REMINDERS TO PROMOTE BEST PRACTICES IN TRAUMA CARE
Grewal, S.
• BROADER ECONOMIC AND SOCIAL IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES IN 73 GAVI COUNTRIES FROM 2001-2020
Griffin, S.
• PREDICTING THE HUI3 AND EQ-5D FROM THE MOS-HIV IN PATIENTS WITH ADVANCED HIV

• ANALYSING DECISION UNCERTAINTY TO INFORM FUNDING AND RESEARCH DECISIONS
Grinberg, A.
• MEDICATION ACTIVATION INFLUENCES DECISIONS REGARDING TREATMENT ESCALATION
Grootendorst, P.
• PREDICTING UTILITY SCORES FOR MYELOFIBROSIS PATIENTS: MAPPING THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM AND MYELOPROLIFERATIVE SYMPTOM ASSESSMENT FORM TO THE EUROQOL-5D

• SOCIAL MEDIA AS A KEY TOOL TO RECRUIT RARE DISEASE PATIENTS FOR CLINICAL RESEARCHERS
Groothuis-Oudshoorn, K. G. M.
• USING BEST-WORST SCALING TO ELICIT PATIENT PREFERENCES FOR SYMPTOM CONTROL, SIDE-EFFECTS AND PROCESS CHARACTERISTICS OF TREATMENTS IN PARKINSON'S DISEASE
Gross, C. P.
• A SIMPLIFIED METHOD FOR ASSESSING COST-EFFECTIVENESS OF PREDICTIVE BIOMARKERS IN ONCOLOGY
Grosse, S.
• COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL NEWBORN SCREENING FOR SEVERE COMBINED IMMUNE DEFICIENCY IN WASHINGTON STATE
Grounds, M. A.
• DECISION-MAKING UNDER UNCERTAINTY: THE EFFECTS OF EXPLICIT PROBABILITY INFORMATION AND RISK PREFERENCES OF DOCTORS
Guinand, S.
• USING PLAN DO CHECK ACT (PDCA) QUALITY IMPROVEMENT CYCLES TO IMPLEMENT PREVENTION RECOMMENDATIONS AMONG PRIMARY CARE PHYSICIANS IN SWITZERLAND
Gupta, A.
• USING MODELING TO PROJECT OPTMIAL CAROTID STENOSIS SCREENING PRACTICES
Gupta, S.
• A COST-EFFECTIVENESS ANALYSIS OF MINIMAL RESIDUAL DISEASE TESTING FOR THE MANAGEMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Gurmankin Levy, A.
• DISHONESTY IN PATIENT DISCLOSURES TO HEALTHCARE PROVIDERS
Gutheil, C.
• FACTORS AFFECTING PHYSICIANS' INTENTIONS TO COMMUNICATE PERSONALIZED PROGNOSTIC INFORMATION TO CANCER PATIENTS AT THE END OF LIFE: AN EXPERIMENTAL VIGNETTE STUDY
Guzauskas, G.
• PHARMACOGENOMICS IMPLEMENTATION: QUANTITATIVE COMPARISON OF EVIDENCE LEVELS FOR PHARMACOGENOMIC- VS. CLINICAL-BASED PERSONALIZED MEDICINE
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z